Mice were inoculated with MOPC315.BM cells and randomized into vehicle-treated mice and GSI XII-treated mice once myeloma-specific monoclonal IgA (M315) serum levels approximated 10–30 μg/ml at two consecutive time points (Figure 3a). Here, CD79A is linked to plasma cell myeloma.